Jeffrey Hatfield
Director/Board Member at VIR BIOTECHNOLOGY, INC.
Net worth: 160 115 $ as of 2024-03-30
Profile
Jeffrey S.
Hatfield is currently the Chairman at Vividion Therapeutics, Inc., Chairman at Rome Therapeutics, Inc., and Independent Director at Vir Biotechnology, Inc. He previously served as the Chief Executive Officer & Director at Zafgen, Inc., President, Chief Executive Officer & Director at Vitae Pharmaceuticals LLC, Chief Executive Officer at Larimar Therapeutics, Inc., Chairman at Viridian Therapeutics, Inc., Director at Ambit Biosciences Corp., Independent Director at aTyr Pharma, Inc., Director at Biotechnology Innovation Organization, Director at InVivo Therapeutics Corp., Independent Director at Invivo Therapeutics Holdings Corp., and Senior VP-Virology & Immunology Divisions at Bristol Myers Squibb Co. He also held positions at Managed Health Care Associates, Inc., Bristol Myers International Group, and Bristol-Myers Squibb Canada Co. Mr. Hatfield received his undergraduate degree from Purdue University and his MBA from The Wharton School of the University of Pennsylvania.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
VIR BIOTECHNOLOGY, INC.
0.01% | 2023-05-21 | 15,806 ( 0.01% ) | 160 115 $ | 2024-03-30 |
Jeffrey Hatfield active positions
| Companies | Position | Start |
|---|---|---|
| VIR BIOTECHNOLOGY, INC. | Director/Board Member | 2020-12-08 |
Vividion Therapeutics, Inc.
 Vividion Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Vividion Therapeutics, Inc. operates as a biotechnology company. The company focuses on developing innovative therapeutics that treat major unmet clinical needs using the first platform for proteome wide drug and target discovery. It's proprietary chemoproteomic platform technology addresses the key limitations of conventional screening techniques and allows the discovery of previously unknown, or cryptic, functional pockets on the surface of proteins and identification of small molecules that selectively bind to those targets. The company was founded by Benjamin F. Cravatt, Phil S. Baran, Jin-Quan Yu and John K. Clarke on December 24, 2013 and is headquartered in San Diego, CA. | Chairman | 2023-01-23 |
Rome Therapeutics, Inc.
 Rome Therapeutics, Inc. BiotechnologyHealth Technology Rome Therapeutics, Inc. develops novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome-vast stretches of uncharted genetic materials. The company was founded by Rosana Kapeller and is headquartered in Cambridge, MA. | Chairman | 2022-07-17 |
Former positions of Jeffrey Hatfield
| Companies | Position | End |
|---|---|---|
| VIRIDIAN THERAPEUTICS, INC. | Chairman | 2021-05-31 |
| ATYR PHARMA, INC. | Director/Board Member | 2021-04-27 |
| INVIVO THERAPEUTICS HOLDINGS CORP. | Director/Board Member | 2018-12-30 |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Director/Board Member | 2016-11-30 |
| VITAE PHARMACEUTICALS INC | Chief Executive Officer | 2016-10-24 |
Training of Jeffrey Hatfield
| Purdue University | Undergraduate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 6 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| ATYR PHARMA, INC. | Health Technology |
| INVIVO THERAPEUTICS HOLDINGS CORP. | Health Technology |
| VIR BIOTECHNOLOGY, INC. | Health Technology |
| VIRIDIAN THERAPEUTICS, INC. | Health Technology |
| LARIMAR THERAPEUTICS, INC. | Health Technology |
| Private companies | 10 |
|---|---|
Ambit Biosciences Corp.
 Ambit Biosciences Corp. Pharmaceuticals: MajorHealth Technology Ambit Biosciences Corp. develops pharmaceutical drugs. It engages in discovery, development and commercialization of small-molecule kinase inhibitors for the treatment of cancer. The firm provides drug to treat unmet medical needs in oncology, autoimmune and inflammatory diseases. The company was founded on May 17, 2000 and is headquartered in San Diego, CA. | Health Technology |
Zafgen, Inc.
 Zafgen, Inc. BiotechnologyHealth Technology Zafgen, Inc. is a biopharmaceutical company, which engages in the development of novel therapies for patients affected by complex metabolic diseases. It focuses on the study of MetAP2 inhibitors in both common and rare metabolic disorders. The firm also advancing programs for type 2 diabetes, Prader-Willi syndrome, and liver diseases. The company was founded on November 22, 2005 and is headquartered in Boston, MA. | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Commercial Services |
InVivo Therapeutics Corp.
 InVivo Therapeutics Corp. BiotechnologyHealth Technology InVivo Therapeutics Corp. operates as a medical device company that develops groundbreaking technologies for the treatment of spinal cord injuries. The company was founded by Joseph P. Vacanti and Robert S. Langer, Jr. in 2005 and is headquartered in Cambridge, MA. | Health Technology |
Managed Health Care Associates, Inc.
 Managed Health Care Associates, Inc. Miscellaneous Commercial ServicesCommercial Services Managed Health Care Associates, Inc. provides management and information technology support services to the healthcare industry. It operates as a health care services and technology company that offers a portfolio of services and solutions to support the diverse and complex needs of the alternate site health care providers. The firm specializes in group purchasing, managed care and payer contracting, reimbursement management, specialty pharmacy solutions, pharmaceutical data analytics, consultant pharmacy software and legislative advocacy services. The company was founded in 1989 and is headquartered in Florham Park, NJ. | Commercial Services |
Vitae Pharmaceuticals LLC
 Vitae Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Vitae Pharmaceuticals LLC is a clinical-stage bio-pharmaceutical company, which engages in discovering and developing novel, small molecule drugs for diseases, including chronic kidney disease, diabetes and Alzheimer's disease, and autoimmune disorders, acute coronary syndrome, and immuno-oncology. The company was founded by John J. Baldwin, Bartosz A. Grzybowski, George M. Whitesides, and Eugene Shakhnovich on May 21, 2001 and is headquartered in Fort Washington, PA. | Health Technology |
| Bristol Myers International Group | |
Bristol-Myers Squibb Canada Co.
 Bristol-Myers Squibb Canada Co. Pharmaceuticals: MajorHealth Technology Bristol-Myers Squibb Canada Co. designs, develops and wholesales pharmaceutical products. The company is headquartered in Halifax, Canada. | Health Technology |
Vividion Therapeutics, Inc.
Vividion Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Vividion Therapeutics, Inc. operates as a biotechnology company. The company focuses on developing innovative therapeutics that treat major unmet clinical needs using the first platform for proteome wide drug and target discovery. It's proprietary chemoproteomic platform technology addresses the key limitations of conventional screening techniques and allows the discovery of previously unknown, or cryptic, functional pockets on the surface of proteins and identification of small molecules that selectively bind to those targets. The company was founded by Benjamin F. Cravatt, Phil S. Baran, Jin-Quan Yu and John K. Clarke on December 24, 2013 and is headquartered in San Diego, CA. | Commercial Services |
Rome Therapeutics, Inc.
Rome Therapeutics, Inc. BiotechnologyHealth Technology Rome Therapeutics, Inc. develops novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome-vast stretches of uncharted genetic materials. The company was founded by Rosana Kapeller and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Jeffrey Hatfield
